Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Appointed director
CC transcript
Auditor change

Acorda Therapeutics, Inc. (ACOR) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/17/2020 GN Aravive Appoints Michael W. Rogers to Board of Directors
03/05/2019 GN Glancy Prongay & Murray LLP Announces Investigation on Behalf of Acorda Therapeutics, Inc. Investors (ACOR)
03/04/2019 GN Detailed Research: Economic Perspectives on Huntsman, eHealth, Ionis Pharmaceuticals, Arch Capital Group, Copart, and Acorda Therapeutics — What Drives Growth in Today's Competitive Landscape
11/08/2018 GN Detailed Research: Economic Perspectives on KB Home, Lennox International, CorVel, Acorda Therapeutics, PROS, and AMAG Pharmaceuticals — What Drives Growth in Today's Competitive Landscape
10/17/2018 GN Investor Expectations to Drive Momentum within SunOpta, Acorda Therapeutics, Sapiens International Corporation N.V, The Descartes Systems Group, Achillion Pharmaceuticals, and CSS Industries — Discovering Underlying Factors of Influence
01/17/2018 GN Kessler Topaz Meltzer & Check, LLP - SHAREHOLDER REMINDER:  Deadline in Class Action Lawsuit Filed Against Acorda Therapeutics, Inc. – ACOR
01/11/2018 GN ACOR ALERT: Rosen Law Firm Reminds Acorda Therapeutics, Inc. Investors of Important January 17 Deadline in Class Action – ACOR
01/06/2018 GN SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acorda Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ACOR
01/04/2018 GN SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Acorda Therapeutics, Inc. (ACOR) & Lead Plaintiff Deadline - January 17, 2018
01/03/2018 GN Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Acorda Therapeutics, Inc. Shareholders
12/21/2017 GN The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Acorda Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of January 17, 2018
12/18/2017 GN EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Acorda Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2018 ?? ACOR
12/18/2017 GN SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Acorda Therapeutics, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
12/04/2017 GN The Klein Law Firm Announces a Class Action Filed on Behalf of Acorda Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of January 17, 2018
12/02/2017 GN SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acorda Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ACOR
11/30/2017 GN IMPORTANT ACORDA THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors who purchased and suffered losses in Acorda Therapeutics, Inc.
11/29/2017 GN SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acorda Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2018 – ACOR
11/29/2017 GN ACORDA THERAPEUTICS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Acorda Therapeutics, Inc. To Contact The Firm
11/27/2017 GN Investor Expectations to Drive Momentum within Acorda Therapeutics, Ellie Mae, NutriSystem, Red Robin Gourmet Burgers, Group 1 Automotive, and ITT — Discovering Underlying Factors of Influence
11/17/2017 GN Pomerantz Law Firm Announces the Filing of a Class Action against Acorda Therapeutics, Inc. and Certain Officers – ACOR

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy